Solara Active Pharma Sciences (NSE:SOLARAPP1) FCF Yield %: 3.60 (As of Jul. 08, 2026)


NSE:SOLARAPP1 Solara Active Pharma Sciences Ltd NSE:SOLARAPP1
68 GF Score
Price ₹267.45
GF Value ₹261.61
! 3 Warning Signs
View Full Analysis

What is Solara Active Pharma Sciences FCF Yield %?

Solara Active Pharma Sciences NSE:SOLARAPP1 68 FCF Yield % is 3.60 as of Jul. 08, 2026. GuruFocus rates NSE:SOLARAPP1 with a GF Score™ of 68/100 and a GF Value™ of ₹261.61. The stock has 3 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Solara Active Pharma Sciences ranks better than 68.62% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Solara Active Pharma Sciences's Trailing 12-Month Free Cash Flow is ₹1,001 Mil, and Market Cap is ₹27,765 Mil. Therefore, Solara Active Pharma Sciences's FCF Yield % for today is 3.60%.

The historical rank and industry rank for Solara Active Pharma Sciences's FCF Yield % or its related term are showing as below:

NSE:SOLARAPP1' s FCF Yield % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 3.6
Current: 3.6


During the past 10 years, the highest FCF Yield % of Solara Active Pharma Sciences was 3.60%. The lowest was 0.00%. And the median was 0.00%.

NSE:SOLARAPP1's FCF Yield % is ranked better than
68.62% of 1007 companies
in the Drug Manufacturers industry
Industry Median: 0.67 vs NSE:SOLARAPP1: 3.60

Solara Active Pharma Sciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.


Solara Active Pharma Sciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Solara Active Pharma Sciences FCF Yield % Related Terms


Solara Active Pharma Sciences FCF Yield % Historical Data

* Premium members only.

The historical data trend for Solara Active Pharma Sciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solara Active Pharma Sciences FCF Yield % Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 13.83 7.77

Solara Active Pharma Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:SOLARAPP1 vs ZTS, UTHR: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solara Active Pharma Sciences FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Solara Active Pharma Sciences's FCF Yield % falls into.


NSE:SOLARAPP1
68GF Score
Solara Active Pharma Sciences Ltd NSE:SOLARAPP1
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solara Active Pharma Sciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Solara Active Pharma Sciences's FCF Yield % for the fiscal year that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=1000.9 / 12883.6014
=7.77%

Solara Active Pharma Sciences's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 12883.6014
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 3.60 mean?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a FCF Yield % of 3.60 as of Jul. 08, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Solara Active Pharma Sciences and its competitors. According to the industry distribution chart, Solara Active Pharma Sciences ranks #316 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 31.4%.
Is Solara Active Pharma Sciences' FCF Yield % too high?
Solara Active Pharma Sciences' current FCF Yield % is 3.60. The Drug Manufacturers industry median FCF Yield % is 0.67. Solara Active Pharma Sciences' value of 3.60 is 437.3% above this industry median. Based on the distribution chart, Solara Active Pharma Sciences ranks #316 out of 1007 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Solara Active Pharma Sciences has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Solara Active Pharma Sciences' FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Solara Active Pharma Sciences ranks #316 out of 1007 companies for FCF Yield %. This puts Solara Active Pharma Sciences in the upper half of its industry. The industry median FCF Yield % is 0.67. Solara Active Pharma Sciences' value of 3.60 is 437.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Solara Active Pharma Sciences's current FCF Yield % of 3.60 is 437.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Solara Active Pharma Sciences and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solara Active Pharma Sciences's current FCF Yield % is 3.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solara Active Pharma Sciences stock overvalued right now?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a current FCF Yield % of 3.60. The stock's GF Value™ is ₹261.61, compared to a current price of ₹267.45 — trading 2.2% above its estimated fair value. The current FCF Yield % is 3.60 and 437.3% above the Drug Manufacturers industry median of 0.67. Solara Active Pharma Sciences' overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Solara Active Pharma Sciences (NSE:SOLARAPP1), the current FCF Yield % is 3.60 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solara Active Pharma Sciences (NSE:SOLARAPP1) Overvalued in 2026?

Based on GuruFocus' analysis, Solara Active Pharma Sciences stock appears to be overvalued. The current stock price of ₹267.45 is trading 2.2% above its estimated GF Value™ of ₹261.61.

Key valuation signals for NSE:SOLARAPP1:

  • FCF Yield %: 3.60
  • GF Value™: ₹261.61 vs. price of ₹267.45 (2.2% above fair value)
  • GF Score™: 68/100 with 3 warning signs
  • Industry Position: 437.3% above the Drug Manufacturers median (#316 of 1007)

No single metric tells the full story. See the NSE:SOLARAPP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Solara Active Pharma Sciences Business Description

Other Exchanges SOLARA:India541540:India
Address Phase II - CSIR Road, Module No. 601, 602, 603, Ticel Bio Park, Taramani, Chennai, TN, IND, 600113
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
68GF Score

Get the complete analysis for NSE:SOLARAPP1

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹267.45
Price
₹261.61
GF Value